Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy

J Control Release. 2022 Apr:344:62-79. doi: 10.1016/j.jconrel.2022.02.020. Epub 2022 Feb 17.

Abstract

Low levels of accumulation and permeability in tumors are two primary reasons for the limited efficacy of conventional antineoplastic nanodrugs. In the present study, based on an original corosolic acid liposome (CALP) carrier with the functions of cell penetration, tumor permeability and anti-inflammation developed by our previous work, a versatile PTX/CALP was achieved by CALP loading paclitaxel (PTX). Compared to conventional PTX liposomes (PTX/LP) prepared by cholesterol and phospholipid, PTX/CALP exhibited extremely increasing cellular uptake and cytotoxicity in vitro, and in vivo enhancing the accumulation and permeability of tumor, thus significantly improving the antitumor efficacy. Further evidence indicated that PTX/CALP conspicuously promoted the recruitment of CD8+ T cells as well as reduced the infiltration of regulatory T cells and M2 macrophages into tumor by inducing enhanced immunogenic cell death (ICD) and down-regulating the inflammation level. Therefore, the improvement of efficacy was also attributed to the superiorities of PTX/CALP in modulating the inflammatory and immunosuppressive tumor microenvironment. Overall, the smart PTX liposomes based on the multi-functional CALP carrier without any modification could overcome the harsh tumor biological barriers, enhance the induction of ICD and then achieve satisfactory efficacy, suggesting its promising potentials in industrial transfer and clinical application.

Keywords: Anti-inflammation; Corosolic acid; Immunomodulation; Liposomes; Paclitaxel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic* / pharmacology
  • Antineoplastic Agents, Phytogenic* / therapeutic use
  • CD8-Positive T-Lymphocytes
  • Cell Line, Tumor
  • Liposomes* / therapeutic use
  • Mice
  • Mice, Inbred BALB C
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents, Phytogenic
  • Liposomes
  • Paclitaxel